{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:16:24Z","timestamp":1763140584539},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/wnf.0b013e318263163c","type":"journal-article","created":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T09:59:29Z","timestamp":1346234369000},"page":"215-223","source":"Crossref","is-referenced-by-count":24,"title":["Immunogenicity and Long-Term Efficacy of Botulinum Toxin Type B in the Treatment of Cervical Dystonia"],"prefix":"10.1097","volume":"35","author":[{"given":"Robert B.","family":"Chinnapongse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark F.","family":"Lew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen L.","family":"Gullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"11","key":"R5-3-20210203","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0149-2918(02)80075-3","article-title":"Immunogenicity of therapeutic proteins: clinical implications and future prospects.","author":"Schellekens","year":"2002","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"R11-3-20210203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-1331.2006.01439.x","article-title":"Immunological aspects of Botox, Dysport, and MyoblocNeuroBloc.","volume":"13","author":"Dressler","year":"2006","journal-title":"Eur J Neurol"},{"key":"R12-3-20210203","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00415-005-0774-3","article-title":"Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure.","volume":"252","author":"Dressler","year":"2005","journal-title":"J Neurol"},{"issue":"7","key":"R13-3-20210203","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/mds.22404","article-title":"Reply: botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: randomized, double-blind, noninferiority trial letter.","volume":"24","author":"Pappert","year":"2009","journal-title":"Mov Disord"},{"issue":"Suppl 2","key":"R16-3-20210203","first-page":"A290","article-title":"A 4 year observational study of repeated dosing with botulinum toxin type B in patients with cervical dystonia abstract.","volume":"66","author":"Lew","year":"2006","journal-title":"Neurology"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e318263163c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:15:04Z","timestamp":1620976504000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201209000-00003"}},"subtitle":["Report of 4 Prospective, Multicenter Trials"],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e318263163c","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}